Global Sepsis Diagnostics Market Worth $564.1 Million by 2021 - Rising Prevalence in Neonate & Adult Population - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Sepsis Diagnostics Market - Global Forecast to 2021" report to their offering.

The sepsis diagnostics market is primarily driven by the rising prevalence of sepsis in the neonate and adult population across the globe. In addition, rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and increasing number of product approvals are supporting the growth of this market. On the other hand, lack of standard protocols and awareness as well as shortage of skilled staff are the major challenges in this market.

In this report, the sepsis diagnostics market has been segmented on the basis of product (instruments, blood culture media, assay kits & reagents, and software), technology (microbiology, molecular diagnostics, immunoassays, and flow cytometry), usability (laboratory testing & point-of-care testing), method (conventional diagnostics and automated diagnostics), pathogen (bacterial sepsis, fungal sepsis, and others) and region (North America, Europe, APAC, and RoW).

On the basis of products, the blood culture media segment is estimated to account for the largest share of the sepsis diagnostics market in 2016. High use of blood culture testing as the standard diagnostic method for the diagnosis and identification of sepsis is driving the growth of this segment across the globe.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the sepsis diagnostics market in 2016, followed by Europe. However, lack of standard protocol for sepsis diagnostics and high cost of diagnostic devices are limiting the growth of sepsis diagnostics market in the North America.

Companies Mentioned:

  • Abbott Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Biomérieux SA
  • Bruker Corporation
  • Cepheid Inc.
  • Nanosphere, Inc.
  • Roche Diagnostics Limited

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Sepsis Diagnostics Market, By Product

7 Sepsis Diagnostics Market, By Technology

8 Sepsis Diagnostics Market, By Method

9 Sepsis Diagnostics Market, By Ability

10 Sepsis Diagnostics Market, By Pathogen

11 Sepsis Diagnostics Market, By Region

12 Competitive Landscape

13 Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/6d2m6j/sepsis

Related Topics: Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716